The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups
A Pingitore,
E Picano,
MQ Colosso,
B Reisenhofer,
G Gigli,
AR Lucarini,
N Petix,
M Previtali,
R Bigi,
G Chiaranda,
G Minardi,
M de Alcantara,
J Lowenstein,
MG Sclavo,
C Palmieri,
A Galati,
G Seveso,
J Heyman,
W Mathias Jr,
F Casazza,
R Sicari,
M Raciti,
P Landi,
and
M Marzilli
Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche (CNR), Pisa, Italy.
OBJECTIVES. This study sought to compare, head to head, the two most popular pharmacologic stress echocardiographic tests--dipyridamole and dobutamine--with state of the art protocols in a large multicenter prospective study. BACKGROUND. In the continuing quest for ideal diagnostic accuracy, pharmacologic stress echocardiography has quickly moved over the years from low to high dose regimens and is currently performed with atropine coadministration. METHODS. Dobutamine (up to 40 microgram/kg body weight per min) plus atropine (up to 1 mg over 4 h) and dipyridamole (up to 0.84 mg/kg per min over 10 h) plus atropine (up to 1 mg over 4 h) stress echocardiography was performed on different days, in random order and within 1 week in 360 patients with chest pain syndrome. Thirteen different echocardiographic laboratories, all fulfilling quality control criteria for stress echocardiographic reading, contributed to the study. RESULTS. No major complications occurred during either test. The test was interrupted before achievement of predetermined end points for limiting side effects in 37 dobutamine-atropine and 7 dipyridamole-atropine stress echocardiographic studies (feasibility 90% vs. 98%, p < 0.01). Diagnostic accuracy was assessed in a subset of 110 patients with no obvious rest dyssynergy (akinesia or dyskinesia) who underwent coronary angiography independently of test results and within 1 week of testing. Significant coronary artery disease (> or = 50% diameter reduction in at least one major coronary vessel by quantitative coronary angiography) was found in 92 patients. Sensitivity for detection of coronary artery disease was 84% (77 of 92) for dobutamine-atropine and 82% (75 of 92) for dipyridamole-atropine stress echocardiography (p = NS), with a specificity of 89% (16 of 18) for dobutamine-atropine and 94% (17 of 18) for dipyridamole-atropine stress echocardiography (p = NS). A significant correlation was present between peak wall motion score index during dipyridamole-atropine and dobutamine-atropine stress echocardiography (r = 0.83, p < 0.0001). CONCLUSIONS. Dobutamine-atropine and dipyridamole-atropine stress echocardiography are safe and feasible, although submaximal studies are more frequent with dobutamine. The two stresses have comparable accuracy in the detection of angiographically assessed coronary artery disease, although dobutamine is marginally more sensitive and dipyridamole marginally more specific. Stratification of the ischemic response in the space domain is also comparable with the two stresses.
This article has been cited by other articles:
|
|
|
|
 
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur. Heart J.,
February 1, 2009;
30(3):
278 - 289.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur J Echocardiogr,
July 1, 2008;
9(4):
415 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Pratali, P. Otasevic, F. Rigo, S. Gherardi, A. Neskovic, and E. Picano
The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy
Eur J Heart Fail,
August 1, 2005;
7(5):
844 - 851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
954 - 970.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)
Circulation,
September 2, 2003;
108(9):
1146 - 1162.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Mathias Jr, J. M. Tsutsui, J. L. Andrade, I. Kowatsch, P. A. Lemos, S. M. B. Leal, B. K. Khandheria, and J. F. Ramires
Value of rapid beta-blocker injectionat peak dobutamine-atropine stressechocardiography for detection of coronary artery disease
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1583 - 1589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kiss, W. Veegh, D. Schragel, C. Bachl, C. Stollberger, and K. Sertl
Bronchial asthma causing symptoms suggestive of angina pectoris
Eur. Respir. J.,
March 1, 2003;
21(3):
473 - 477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Sitges, C Pare, M Azqueta, X Bosch, M VelamazaN, J Magrina, and G Sanz
Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina
Eur. Heart J.,
July 1, 2000;
21(13):
1063 - 1071.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Varga
Pharmacologic stress echocardiography: can we forget "state-of-the-art" protocols?
J. Am. Coll. Cardiol.,
June 1, 2000;
35(7):
1994 - 1995.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pingitore, E. Picano, A. Varga, G. Gigli, L. Cortigiani, M. Previtali, G. Minardi, M. Quarta Colosso, J. Lowenstein, W. Mathias Jr., et al.
Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
J. Am. Coll. Cardiol.,
November 15, 1999;
34(6):
1769 - 1777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hoffmann, H. Lethen, H. Kuhl, W. Lepper, and P. Hanrath
Extent and severity of test positivity during dobutamine stress echocardiography. Influence on the predictive value for coronary artery disease
Eur. Heart J.,
October 2, 1999;
20(20):
1485 - 1492.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol.,
June 1, 1999;
33(7):
2092 - 2197.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Beleslin, M. Ostojic, A. Djordjevic-Dikic, R. Babic, M. Nedeljkovic, G. Stankovic, S. Stojkovic, J. Marinkovic, I. Nedeljkovic, J. Stepanovic, et al.
Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology
J. Am. Coll. Cardiol.,
March 1, 1999;
33(3):
717 - 726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Nagel, H. B. Lehmkuhl, W. Bocksch, C. Klein, U. Vogel, E. Frantz, A. Ellmer, S. Dreysse, and E. Fleck
Noninvasive Diagnosis of Ischemia-Induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI : Comparison With Dobutamine Stress Echocardiography
Circulation,
February 16, 1999;
99(6):
763 - 770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cortigiani, E. A. Paolini, and E. Nannini
Dipyridamole Stress Echocardiography for Risk Stratification in Hypertensive Patients With Chest Pain
Circulation,
December 22, 1998;
98(25):
2855 - 2859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cortigiani, C. Dodi, E. A. Paolini, D. Bernardi, G. Bruno, and E. Nannini
Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease
J. Am. Coll. Cardiol.,
December 1, 1998;
32(7):
1975 - 1981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés
Selection of the optimal stress test for the diagnosis of coronary artery disease
Heart,
October 1, 1998;
80(4):
370 - 376.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. Cortigiani, E. Picano, P. Landi, M. Previtali, S. Pirelli, P. Bellotti, R. Bigi, O. Magaia, A. Galati, E. Nannini, et al.
Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the echo-persantine and echo-dobutamine international cooperative studies
J. Am. Coll. Cardiol.,
July 1, 1998;
32(1):
69 - 74.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
